|
Leigh's Disease
What is Leigh's Disease?
Leigh's disease is a rare inherited neurometabolic disorder characterized by
degeneration of the central nervous system. Leigh's disease can be caused by
mutations in mitochondrial DNA or by deficiencies of an enzyme called pyruvate
dehydrogenase. Symptoms of Leigh's disease usually begin between the ages of 3
months to 2 years and progress rapidly. In most children, the first signs may be
poor sucking ability and loss of head control and motor skills. These symptoms
may be accompanied by loss of appetite, vomiting, irritability, continuous
crying, and seizures. As the disorder progresses, symptoms may also include
generalized weakness, lack of muscle tone, and episodes of lactic acidosis,
which can lead to impairment of respiratory and kidney function. Heart problems
may also occur. In rare cases, Leigh's disease can begin during late adolescence
or early adulthood and progress more slowly.
Is there any treatment?
The most common treatment for Leigh's disease is thiamine or Vitamin B1. In
patients who have a deficiency of pyruvate dehydrogenase enzyme complex, a
high-fat, low-carbohydrate diet may be recommended. Oral sodium bicarbonate or
sodium citrate may also be prescribed to manage lactic acidosis. Experimental
protocols are currently using dichloroacetate to treat patients with lactic
acidosis.
What is the prognosis?
The prognosis for individuals with Leigh's disease is poor. Individuals who
lack mitochondrial complex IV activity and those with pyruvate dehydrogenase
deficiency tend to have the worst prognosis and die within a few years. Those
with partial deficiencies have a better prognosis, and may live to be 6 or 7
years of age. Some have survived to their mid-teenage years.
What research is being done?
The NINDS supports and encourages a broad range of basic and clinical research
on neurogenetic disorders such as Leigh's disease. The goal of this research
is to understand what causes these disorders and then to apply these findings
to new ways to diagnose, treat, and prevent them. Organizations
Epilepsy Foundation
8301 Professional Place
Landover, MD 20785-7223
postmaster@efa.org
http://www.epilepsyfoundation.org
Tel: 301-459-3700 800-EFA-1000 (332-1000)
Fax: 301-577-2684 |
National Organization for Rare Disorders (NORD)
P.O. Box 1968
(55 Kenosia Avenue)
Danbury, CT 06813-1968
orphan@rarediseases.org
http://www.rarediseases.org
Tel: 203-744-0100 Voice Mail 800-999-NORD (6673)
Fax: 203-798-2291 |
United Mitochondrial Disease Foundation
8085 Saltsburg Road Suite 201
Pittsburgh, PA 15239
info@umdf.org
http://www.umdf.org
Tel: 412-793-8077
Fax: 412-793-6477 |
Source: National Institutes of Health; National Institute of
Neurological Disorders and Stroke
index#6037
|